ARCHIVES

Letter to the Editors: Burzynski Responds To FDA Release Of Annual Report Data

This article is from The Cancer Letter archive.

Vol. 24 No. 20 | May 22, 1998

Download PDF Visit The Full Archive

Related Articles

Rituximab After CVP Improves Progression-Free Survival

March 27, 2009

Bristol To Support Grants For Studies On Drug Resistance

June 26, 1987

FASEB Report On NIH Funding Urges Sustained Growth In Fiscal Year 2011

April 16, 2010

Fisher To Direct Wilmot CC

October 5, 2001

Two Breast Cancer Treatments Show Similar Benefit In Trial

December 30, 2005

HCFA Draft Document Dampens Jubilation Over Clinton Plan To Pay Patient Care Costs.

June 16, 2000